Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PE8P
|
|||
| Former ID |
DNC001583
|
|||
| Drug Name |
PD173212
|
|||
| Synonyms |
PD 173212; 217171-01-2; PD173212; CHEMBL299749; N-[[4-(1,1-dimethylethyl)phenyl]methyl]-N-methyl-L-leucyl-N-(1,1-dimethylethyl)-O-(phenylmethyl)-L-Tyrosinamide; SCHEMBL8188148; DTXSID10432752; MolPort-006-822-718; ZINC3941150; BDBM50078723; ABP000999; AKOS024457680; CS-7879; NCGC00347242-02; DB-066610; HY-103318; B7424; FT-0773764; J-014254; N-[[4-(1,1-Dimethylethyl)phenyl]methyl-N-methyl-L-leucyl-N-(1,1-dimethylethyl)-O-phenylmethyl)-L-tyrosinamide; (S)-2-[(4-tert-Butyl-benzyl)-methyl-amino]-4-methyl-pentanoic acid [(S)-2-(4-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Pain [ICD-11: MG30-MG3Z] | Investigative | [1] | |
| Therapeutic Class |
Analgesics
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C38H53N3O3
|
|||
| Canonical SMILES |
CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)OCC2=CC=CC=C2)C(=O)NC(C)(C)C)N(C)CC3=CC=C(C=C3)C(C)(C)C
|
|||
| InChI |
1S/C38H53N3O3/c1-27(2)23-34(41(9)25-29-15-19-31(20-16-29)37(3,4)5)36(43)39-33(35(42)40-38(6,7)8)24-28-17-21-32(22-18-28)44-26-30-13-11-10-12-14-30/h10-22,27,33-34H,23-26H2,1-9H3,(H,39,43)(H,40,42)/t33-,34-/m0/s1
|
|||
| InChIKey |
GCDHMGROXQUFNR-HEVIKAOCSA-N
|
|||
| CAS Number |
CAS 217171-01-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Voltage-gated L-type calcium channel (L-CaC) | Target Info | Blocker | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Recent updates of N-type calcium channel blockers with therapeutic potential for neuropathic pain and stroke. Curr Top Med Chem. 2009;9(4):377-95. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.